Clinical Utility of Zuranolone for Postpartum Depression: A Narrative Review
Athanasia Giannopoulos,1 Joshna Singh,2 Kristina M Deligiannidis1,3 1Division of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, New York, NY, USA; 2Department of Psychiatry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; 3Feinstein Insti...
Saved in:
| Main Authors: | Giannopoulos A, Singh J, Deligiannidis KM |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-utility-of-zuranolone-for-postpartum-depression-a-narrative-r-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FDA‐Approved Zuranolone: First Oral Treatment for Postpartum Depression, Ushering in a New Era of Hope; A Narrative Review
by: Muhammad Haris, et al.
Published: (2025-03-01) -
Zuranolone for postpartum depression: a systematic review and meta-analysis of two randomized studies
by: Juliana Almeida Oliveira, et al.
Published: (2025-01-01) -
Treatment of Postpartum Depression with Neurosteroids
by: Reda Stankevičiūtė, et al.
Published: (2024-03-01) -
Post marketing safety assessment of the novel postpartum depression drug, Zuranolone: evidence from real-world pharmacovigilance analysis based on the FDA adverse event reporting system
by: Duoqin Huang, et al.
Published: (2025-08-01) -
Peripartum depression: Current considerations on classification, biological importance and therapeutic potential of neuroactive steroids
by: Marković Miloš, et al.
Published: (2022-01-01)